BrianwaveBank wins at Innovation Awards 2018

Clarendon portfolio company, Belfast-based BrainWaveBank won the Life Sciences and Healthcare award at The Irish Times Innovation Awards 2018 for its ‘fitbit for the brain’ which has the potential to enable much earlier diagnosis of Alzheimer’s and other degenerative brain diseases with a view to facilitating earlier and hopefully more effective treatment of these conditions. The technology has been proven in a number of demonstrator trials and the company has just been asked by the Northern Ireland department of health to work on research into pre-psychosis in teenagers.

The awards, which are now in their ninth year, were presented at a ceremony attended by more than 200 people at the RDS concert hall last night. More than 270 companies registered for the awards this year. Some 87 final applicants made it to the first round of judging.

The Irish Times Innovation Awards 2018 are supported by The Irish Times in partnership with Science Foundation Ireland, KPMG, Enterprise Ireland and UCD Michael Smurfit Graduate Business School.

Pictured above are the company’s CEO Ronan Cunningham (right) and CSO Brian Murphy.

 

Share the Post:

Related Posts

Clarendon is hiring a Portfolio and Finance Manager

Join Clarendon Fund Managers as Portfolio and Finance Manager

Clarendon Fund Managers, a B Corp-certified venture capital firm based in Belfast, is looking for a Portfolio and Finance Manager to join our growing team. With a mission to back high-potential companies and drive economic growth in Northern Ireland, we support a diverse and inclusive culture where collaboration, impact and excellence are at the core of what we do.

This is a full-time, permanent position, reporting to the Finance Director, with flexible and hybrid working options available.  It’s a key role at the intersection of fund finance, operations, and investor relations.

Read More
Reform RX and CFM teams

Acquisition of Pilates experts ReformRX marks first exit for Investment Fund for Northern Ireland Equity Fund

Pilates reformer manufacturer Reform RX has become the first exit for the Investment Fund for Northern Ireland (IFNI) after the company was acquired by US-based connected fitness equipment leader iFIT Inc for an undisclosed sum.

The IFNI was launched by The British Business Bank to tackle an identified funding gap, with the aim of driving sustainable economic growth by supporting innovation and creating opportunities for new and scaling businesses.

Read More

ABOUT US

Clarendon Fund Managers Limited is a venture capital fund manager based in Belfast, authorised and regulated by the Financial Conduct Authority.

ADDITIONAL LINKS

Copyright information
Legal Disclaimer
Privacy Information

5th Floor
Craig Plaza
51 Fountain Street
Belfast, BT1 5EA
Co. Antrim
T: +44 (0)28 9032 6465
F: +44 (0)28 9032 6473
E: info@clarendon-fm.co.uk

X-twitter Linkedin

Clarendon Fund Managers Limited is authorised and regulated by the Financial Conduct Authority
The content of the information and materials on the Website and any other information and materials provided by or though CFM in connection with Co-Fund NI and associated investment opportunities and Investee Companies, including any financial promotion as defined in Financial Services and Markets as Act 2000(“FSMA”) constituted thereby, has not been approved by an authorised person within the meaning of FSMA. Reliance on the information provided in relation to any specific Investee Company or otherwise, including any financial promotion constituted thereby, for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.

© 2025 Clarendon Fund Managers. All rights reserved.